Literature DB >> 22427408

Mapping pathogenesis of arthritis through small animal models.

Tonia L Vincent1, Richard O Williams, Rose Maciewicz, Alan Silman, Paul Garside.   

Abstract

Animal models have been used for a number of decades to study arthritis and have contributed greatly to unravelling mechanisms of pathogenesis and validating new targets for treatment. All animal models have sets of limitations and over the years there has been natural refinement of existing models as well as creation of new ones. The success of genetic modification in mice has fuelled an exponential increase in the use of murine models for arthritis research and has significantly increased our understanding of disease processes. This review focuses on those rodent models of RA and OA that have current utility and are widely used by the research community. We highlight the subtle but important differences in existing models by positioning them on a pathogenesis map whereby model selection is determined by the specific aspect of disease to be studied. We discuss the evolving challenges in in vivo arthritis studies and our perceived gaps for future new model development. The document includes technical and cost implications of performing the described models, and the ethical considerations of such approaches.

Entities:  

Mesh:

Year:  2012        PMID: 22427408     DOI: 10.1093/rheumatology/kes035

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  53 in total

Review 1.  Mechanisms, impact and management of pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Nat Rev Rheumatol       Date:  2014-05-27       Impact factor: 20.543

Review 2.  Calcitonin gene-related peptide in the joint: contributions to pain and inflammation.

Authors:  David A Walsh; Paul I Mapp; Sara Kelly
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

3.  Intra-articular (IA) ropivacaine microparticle suspensions reduce pain, inflammation, cytokine, and substance p levels significantly more than oral or IA celecoxib in a rat model of arthritis.

Authors:  Barrett Rabinow; Jane Werling; Alison Bendele; Jerome Gass; Roy Bogseth; Kelly Balla; Paul Valaitis; Audrey Hutchcraft; Sabine Graham
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 4.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

5.  Clinical strategies and animal models for developing senolytic agents.

Authors:  James L Kirkland; Tamara Tchkonia
Journal:  Exp Gerontol       Date:  2014-10-28       Impact factor: 4.032

Review 6.  Useful animal models for the research of osteoarthritis.

Authors:  Kalliopi Lampropoulou-Adamidou; Pavlos Lelovas; Eleftherios V Karadimas; Chrysoula Liakou; Ioannis K Triantafillopoulos; Ismene Dontas; Nikolaos A Papaioannou
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-03-13

Review 7.  An overview of animal models of pain: disease models and outcome measures.

Authors:  Nicholas S Gregory; Amber L Harris; Caleb R Robinson; Patrick M Dougherty; Perry N Fuchs; Kathleen A Sluka
Journal:  J Pain       Date:  2013-09-12       Impact factor: 5.820

Review 8.  Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics.

Authors:  David J Wilkinson; Maria Del Carmen Arques; Carmen Huesa; Andrew D Rowan
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

9.  Maximising the output of osteoarthritis research: the ARRIVE guidelines.

Authors:  N Percie du Sert
Journal:  Osteoarthritis Cartilage       Date:  2012-02-02       Impact factor: 6.576

Review 10.  Cellular imaging in rheumatic diseases.

Authors:  Robert A Benson; Iain B McInnes; James M Brewer; Paul Garside
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.